Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
Código da empresaAMIX
Nome da EmpresaAutonomix Medical Inc
Data de listagemJan 29, 2024
CEOHauser (Bradley)
Número de funcionários8
Tipo de títulosOrdinary Share
Fim do ano fiscalJan 29
Endereço21 Waterway Ave, Suite 300
CidadeTHE WOODLANDS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal77380
Telefone18322777816
Sitehttps://autonomix.com/
Código da empresaAMIX
Data de listagemJan 29, 2024
CEOHauser (Bradley)
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados